| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 6.5 | 69.4 | 0.0 |
| Other income | 0.1 | 0.4 | 0.8 |
| Total income | 6.6 | 69.7 | 0.8 |
| Profit before exceptional items & tax | 0.3 | 53.5 | -1.0 |
| Exceptional items | 0.0 | -0.2 | 0.0 |
| Profit before tax | 0.3 | 53.4 | -1.0 |
| Net profit | 0.3 | 39.7 | -1.1 |
| Operating margin | 4.5% | 76.6% | -125.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | -99.20% |
|---|---|
| Operating profit, year on year | +111.10% |
| Operating profit, quarter on quarter | -99.60% |
BSE results filing, NSE: SUNSHINE. Figures extracted from the filing.
Sunshine Pictures Ltd: key numbers
- Share price
- ₹437.45
- Market cap
- ₹1,363 Cr
- Revenue (annual)
- ₹74.44 Cr
- Net profit (annual)
- ₹40.02 Cr
- Promoter holding
- 74.84%
- FII holding
- 2.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sunshine Pictures Ltd
All →Sunshine Pictures Business Update
Sunshine Pictures outlines its growth strategy, content pipeline, and multi-platform monetization approach. It notes Q1 FY27 revenue recognition was limited due to project cycles.
Sunshine Pictures Board Meeting Date
Sunshine Pictures intimated BSE that its Board meets on 15/09/2026. The agenda includes approving unaudited Q1 FY27 standalone results.
Johnson Pharmacare Q1 FY27 Results: Net Loss of ₹1.1 Cr, Loss Widens
Johnson Pharmacare Ltd reported a net loss of ₹1.1 Cr for Q1 FY27.
- Key figure
- Net loss ₹1.1 Cr
Johnson Pharmacare Q4 FY26 Results: Net Loss of ₹55.6 Cr, Loss Widens
Johnson Pharmacare Ltd reported a net loss of ₹55.6 Cr for Q4 FY26.
- Key figure
- Net loss ₹55.6 Cr